Danielle Rebibo
Agence française de sécurité sanitaire des produits de santé
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Danielle Rebibo.
Transfusion | 2002
Georges Andreu; P. Morel; Francois Forestier; Joëlle Debeir; Danielle Rebibo; Gérard Janvier; Patrick Herve
BACKGROUND : Hemovigilance networks have been introduced in several countries to improve knowledge of blood transfusion‐related morbidity and mortality. The general organization of the French network and its results from 1994 through March 1999 are presented here.
Transfusion | 2011
Yves Ozier; Jean-Yves Muller; Paul-Michel Mertes; Philippe Renaudier; Philippe Aguilon; N. Canivet; P. Fabrigli; Danielle Rebibo; Mahdi Tazerout; Catherine Trophilme; Béatrice Willaert; Cyril Caldani
BACKGROUND: Transfusion‐related acute lung injury (TRALI) is a major cause of transfusion‐related mortality and morbidity. Epidemiologic studies using data from national transfusion schemes can help achieve a better understanding of TRALI incidence.
Transfusion | 2015
Bruno Lafeuillade; François Eb; Nadra Ounnoughene; Rachel Petermann; Gérald Daurat; Gérard Huyghe; Mai-Phuong Vo Mai; Cyril Caldani; Danielle Rebibo; Pierre Weinbreck
Regarding blood safety, transfusion‐transmitted bacterial infection (TTBI) remains the most frequent infectious risk. The incidence of these episodes needs to be assessed and updated frequently to accurately manage this risk.
Revista Brasileira De Hematologia E Hemoterapia | 2000
Patrick Hervé; Marie-Françoise Leconte des Floris; Danielle Rebibo; Pascal Morei; Georges Andreu
No relato sao apresentados aspectos da organizacao da hemovigilância na Franca, o sistema de alerta relacionado com reacoes transfusionais indesejaveis e a busca de receptores sorologicamente positivos.
Transfusion Clinique Et Biologique | 2010
Yves Ozier; Philippe Renaudier; Cyril Caldani; P. Aguilon; N. Canivet; P. Fabrigli; Paul-Michel Mertes; Jean-Yves Muller; Danielle Rebibo; M. Tazerout; C. Trophilme; Béatrice Willaert; M. Carlier
Pulmonary oedema after transfusion of blood products may be hydrostatic (transfusion-associated circulatory overload [taco]) or exsudative (transfusion-related acute lung injury [trali]). Both conditions have been recognized as major hazards to transfusion recipients. Risk characterization is necessary to improve safety and to monitor trends in the national blood transfusion system. A collaborative multidisciplinary working group of the French National Hemovigilance Committee has proposed an analysis framework for case definitions and classification. The method relies on internationally used definitions and is adapted to the codification procedures used in the french transfusion incident reports electronic data management.
Transfusion Medicine and Hemotherapy | 2008
Philippe Renaudier; Syvie Schlanger; Mai-Phuong Vo Mai; Nadra Ounnoughene; Pascal Breton; Stéphane Cheze; Albane Girard; Lisette Hauser; Jean François Legras; Hélène Odent-Malaure; Danielle Rebibo; Chantal Waller; Béatrice Willaert; Cyril Caldani
The French Hemovigilance Network has been established in 1994 and records all adverse events associated with the transfusion of a labile blood products (LBP) regardless of their severity. From 1994 to 2006 35,423,172 LBP were issued, 85,812 adverse transfusion reactions notified, and 139 cases of transfusion related acute lung injury (TRALI) observed. The LBP most at risk is fresh frozen plasma (FFP), followed by platelets concentrates (PC) and packed red cells (PRC). However, because the use of FFP is not frequent in France, it only accounts for about 10% of TRALI, whereas PRC and PC are involved in the remaining cases. In no case, pooled FFP treated with solvent-detergent were involved. Patients’ profiles are peculiar with a high disease burden. Therefore, targeting a prevention policy only on FFP would result in a marginal reduction of TRALI in France.
Transfusion Clinique Et Biologique | 2010
I. Hervé; M. Simonet; Danielle Rebibo; M.-F. Leconte des Floris; M. Taouqi-Le Cann; S. Jbilou; A. Brunet
Post donation information management is a fundamental axis of haemovigilance in terms of blood safety. It requires an organization ensuring a permanent reactivity, a good sensitization of French National Blood Service professionals and needs also a strong awareness of blood donors. Previous identification of stakeholders to warn during these kinds of alerts is essential to avoid the use of any blood product presenting a potential risk. The recent implementation of a consensual internal document aims to target the reinforcement of a homogeneous decision-making process, combining blood product self-sufficiency and above all recipient safety.
Transfusion Medicine and Hemotherapy | 2008
Hans-Gert Heuft; Wolfgang Mende; Rainer Blasczyk; Franz Weinauer; Béatrice Willaert; Mai-Phuong Vo Mai; Cyril Caldani; Philippe Renaudier; Syvie Schlanger; Nadra Ounnoughene; Pascal Breton; Stéphane Cheze; Albane Girard; Lisette Hauser; Jean François Legras; Hélène Odent-Malaure; Danielle Rebibo; Chantal Waller; Catherine E. Chapman; Lorna M. Williamson; Markus Jutzi; Guy Levy; Behrouz Mansouri Taleghani; Peter Hellstern; Walter E. Hitzler; Britta Engelhardt; Mark A. Popovsky; Matthias Hecker; Hans-Dieter Walmrath; Werner Seeger
Service
Transfusion and Apheresis Science | 2004
Danielle Rebibo; Lisette Hauser; Ahmed Slimani; Patrick Herve; Georges Andreu
The Journal of Allergy and Clinical Immunology | 2012
Paul-Michel Mertes; P. Demoly; Annick Alpérovitch; A. Bazin; Jacques Bienvenu; Cyril Caldani; Bernard Lamy; Dominique Laroche; Marie-Françoise Leconte des Floris; Jean-Yves Py; Danielle Rebibo; Béatrice Willaert; Christian Drouet; M. Carlier; André Lienhart
Collaboration
Dive into the Danielle Rebibo's collaboration.
Agence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputs